L'invention concerne galement l'utilisation de la L-lysine pour potentialiser l'effet de la L-carnitine dans la prparation d'un mdicament destin au traitement des perturbations musculaires lies une hypoexcitabilit ou une hypocontractilit.The invention also relates to the use of L-lysine to potentiate the effect of L-carnitine in the preparation of a medicament intended for the treatment of muscular disturbances linked to hypoexcitability or hypocontractility
Key Features: High Potency Formula: Each ml contains a high concentration of L-Carnitine, ensuring maximum effectiveness and efficiency in every dose
The Pharmacodynamics, Pharmacokinetics, and Safety of Arhalofenate in Combination with Febuxostat When Treating Hyperuricemia Associated with Gout
Clomiphene citrate: the changing landscape
10.7812/TPP/21.204 Shetty R, Deshpande K, Ghosh A, Sethu S: Management of Ocular Neuropathic Pain With Vitamin B12 Supplements: A Case Report
What are the differences between Tesamorelin vs Ipamorelin